{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Martin Arnold", "title": "Eurozone economic downturn looms as business orders fall - Financial Times", "description": "Euro hits six-month low and investors bet against more interest rate rises after release of PMIs", "url": "https://www.ft.com/content/148adc6b-98f3-4655-a92b-913a232c9eef", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F436b16ed-b9a0-4d2b-b2c0-90882905fda9.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-09-22T12:54:27Z", "content": "A majority of eurozone businesses reported continued falls in activity and new orders this month, according to a closely watched survey that signals a likely economic contraction. \r\nAt 47.1, the head\u2026 [+3877 chars]"}, {"source": {"id": null, "name": "Astrazeneca.com"}, "author": null, "title": "Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial - AstraZeneca", "description": "", "url": "https://www.astrazeneca.com/media-centre/press-releases/2023/dato-dxd-improved-pfs-in-breast-cancer.html", "urlToImage": "", "publishedAt": "2023-09-22T01:30:00Z", "content": "Positive high-level results from the TROPION-Breast01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant and clinically meaningful improvement for the p\u2026 [+9913 chars]"}]}